Want to see SG:8YY full AI Analyst Report?
Biolidics Ltd. (8YY) Income Statement
Biolidics Ltd. Income Statement
Last quarter (Q2 2026), Biolidics Ltd.'s total revenue was $3.31M, an increase of 7975.61% from the same quarter last year. In Q2, Biolidics Ltd.'s net income was $288.00K. See Biolidics Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 5.26M | $ 784.00K | $ 277.00K | $ 2.49M | $ 2.31M | |
| $ 1.94M | $ 187.00K | $ 146.00K | $ 1.16M | $ 483.00K | |
| $ 5.16M | $ 1.89M | $ 1.14M | $ 4.20M | $ 3.79M | |
| Depreciation and Amortization | $ 263.00K | $ 120.00K | $ 241.00K | $ 1.18M | $ 1.25M |
| $ -3.65M | $ -3.03M | $ -1.16M | $ -8.50M | $ -4.58M | |
| $ -3.22M | $ -1.70M | $ -996.00K | $ -3.04M | $ -3.31M | |
| $ -772.00K | $ -1.49M | $ -518.00K | $ -6.82M | $ -2.73M | |
| $ -3.99M | $ -3.19M | $ -1.51M | $ -9.85M | $ -6.04M | |
| $ -3.96M | $ -3.43M | $ -2.49M | $ -9.37M | $ -5.98M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ 0.00 | $ 0.00 | $ -0.03 | $ -0.02 |
| Diluted EPS | $ -0.00 | $ 0.00 | $ 0.00 | $ -0.03 | $ -0.02 |
| Weighted Average Shares Outstanding | 1.71B | 981.26M | 593.13M | 281.69M | 264.99M |
| Weighted Average Shares Outstanding (Diluted) | 1.71B | 981.26M | 593.13M | 281.69M | 265.21M |
Currency in SGD